id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-3517-0033,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry;
Availability",Notice,Notice of Availability,2025-01-07T05:00:00Z,2025,1,,,2025-01-07T21:44:50Z,2024-31546,0,0,09000064868a2da5
FDA-2015-D-3517-0034,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry",Other,Guidance,2025-01-07T05:00:00Z,2025,1,2025-01-07T05:00:00Z,,2025-02-07T02:01:17Z,,1,0,09000064868a5abc
FDA-2015-D-3517-0021,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2023-12-07T05:00:00Z,2023,12,2023-12-07T05:00:00Z,,2023-12-07T14:38:58Z,2023-26886,0,0,09000064863099ff
FDA-2015-D-3517-0022,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry",Other,Guidance,2023-12-07T05:00:00Z,2023,12,2023-12-07T05:00:00Z,2024-01-09T04:59:59Z,2025-01-07T21:45:09Z,,0,0,090000648630bbb2
FDA-2015-D-3517-0017,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry",Other,Guidance,2016-06-10T04:00:00Z,2016,6,2016-06-10T04:00:00Z,,2025-01-07T21:45:03Z,,0,0,090000648202e5c4
FDA-2015-D-3517-0016,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability",Notice,Correction,2016-06-10T04:00:00Z,2016,6,2016-06-10T04:00:00Z,,2016-06-16T17:48:35Z,2016-13799,0,0,090000648202c0de
FDA-2015-D-3517-0001,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Draft Guidance; Availability",Notice,Notice of Availability,2015-10-27T04:00:00Z,2015,10,2015-10-27T04:00:00Z,2015-12-29T04:59:59Z,2015-12-29T22:01:04Z,2015-27269,0,0,0900006481cf151f
FDA-2015-D-3517-0002,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act ; Draft Guidance for Industry",Other,Guidance,2015-10-27T04:00:00Z,2015,10,2015-10-27T04:00:00Z,,2019-08-22T19:09:10Z,,0,0,0900006481cf1c02